The Checkup: ‘Junk patents’ by big pharma lead to soaring drugs prices, FTC says
The Federal Trade Commission says drug makers are gaming the system in order to keep drug prices high by filing what it describes as “junk patents”.
The Federal Trade Commission says drug makers are gaming the system in order to keep drug prices high by filing what it describes as “junk patents”.
Republicans loved the made-for-television moments in President Trump’s third State of the Union speech as he made his case for reelection. Democrats did not.